✦ LIBER ✦

Combination chemotherapy beneficial for refractory ITP

Book ID: 120867568
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2001
Weight: 138 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200112870-00040

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab may be beneficial in chronic r

Rituximab may be beneficial in chronic refractory ITP

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 136 KB

Combination therapy for a pregnant woman

Combination therapy for a pregnant woman with severe refractory ITP

✍ Makoto Orisaka; Ken-ichi Shukunami; Sanae Orisaka; Kenji Goto; Yoshio Yoshida; F 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Combination chemotherapy regimen benefic

Combination chemotherapy regimen beneficial in AML

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 121 KB

Combination chemotherapy beneficial in i

Combination chemotherapy beneficial in inoperable liver cancer

📂 Article 📅 1999 🏛 Adis International Limited (now part of Wolters Kl ⚖ 181 KB

Combination chemotherapy for hormone-ref

Combination chemotherapy for hormone-refractory prostate carcinoma : Progress and pitfalls

✍ Samira Syed 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB

Although there has been progress in the development of chemotherapy combinations with enhanced activity in patients with hormone‐refractory prostate carcinoma, the innate lack of selectivity to tumor cells with those combinations has resulted in diminishing returns and has approached the limits of a

Corticosteroid is not beneficial in mult

Corticosteroid is not beneficial in multiple-drug combination chemotherapy for multiple myeloma

✍ I. P. Palva; K. Ala-Harja; A. Almqvist; E. Elonen; H. Hallman; A. Hänninen; M. I 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB